4-ANTIBODY AG

4-antibody-ag-logo

4-Antibody AG develops human antibody drug-discovery platform for generating antibody therapeutics focused on immuno-oncology. Its technology platform Retrocyte Display is designed to generate therapeutic antibody drug candidates incorporating human antibody libraries expressed in mammalian B-lineage lymphocytes. The company also develops preclinical checkpoint antibody programs targeting GITR, OX40, CTLA-4, PD-1, TIM-3, and LAG-3. 4-Antibody AG was founded in 2002 and is based in Basel, Switzerland.

#SimilarOrganizations #People #Financial #Website #More

4-ANTIBODY AG

Industry:
Biotechnology Health Care Medical Therapeutics

Founded:
2002-01-01

Address:
Basel, Basel-Stadt, Switzerland

Country:
Switzerland

Website Url:
http://www.4-antibody.com

Total Employee:
251+

Status:
Active

Contact:
+41616332260

Total Funding:
25.75 M CHF

Technology used in webpage:
SPF IPv6 Microsoft Azure DNS PHP Microsoft DNS Made Easy DNS DNS Made Easy Tiggee


Similar Organizations

chimeron-bio-logo

Chimeron Bio

Chimeron Bio develops agents for personalized cancer gene therapy.

interline-therapeutics-logo

Interline Therapeutics

Interline Therapeutics is a drug discovery platform that enables the company to map and correct dysfunctional protein communities.

Current Employees Featured

not_available_image

Robert F Burns
Robert F Burns Chief Executive Officer @ 4-Antibody AG
Chief Executive Officer

Investors List

grazia-equity_image

Grazia Equity

Grazia Equity investment in Series A - 4-Antibody AG

life-sciences-partners_image

Life Sciences Partners

Life Sciences Partners investment in Series A - 4-Antibody AG

advent-venture-partners_image

Advent Venture Partners

Advent Venture Partners investment in Series A - 4-Antibody AG

life-sciences-partners_image

Life Sciences Partners

Life Sciences Partners investment in Seed Round - 4-Antibody AG

grazia-equity_image

Grazia Equity

Grazia Equity investment in Seed Round - 4-Antibody AG

biomedpartners_image

BioMedPartners

BioMedPartners investment in Seed Round - 4-Antibody AG

mulligan-biocapital_image

Mulligan BioCapital

Mulligan BioCapital investment in Seed Round - 4-Antibody AG

Official Site Inspections

http://www.4-antibody.com

  • Host name: redirection.dnsmadeeasy.com
  • IP address: 96.45.83.110
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "4-Antibody AG" on Search Engine